Clinical Trial Update: Adipocyte, Insulin-resistance and Immunity : Evaluation of Interleukin-7 in Lipodystrophy, Diabetes and Obesity

View source ↗

Summary

A clinical trial evaluating interleukin-7 for lipodystrophy, obesity, and type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lipodystrophy
• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• Interleukin-7 (interleukin-7)

Snippet

Sponsor: University Hospital, Lille | Conditions: Lipodystrophy, Obesity | Status: COMPLETED